BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyran, S
Right arrow Articles by Edward, D P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toyran, S
Right arrow Articles by Edward, D P
British Journal of Ophthalmology 2005;89:885-890
© 2005 BMJ Publishing Group Ltd


EXTENDED REPORT

Expression of growth differentiation factor-5 and bone morphogenic protein-7 in intraocular osseous metaplasia

S Toyran1, A Y Lin2, D P Edward1,2

1 Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA
2 Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA

Correspondence to:
Correspondence to:
Deepak P Edward
MD, Department of Ophthalmology, University of Illinois at Chicago, 1905 W Taylor Street, L217, Chicago, IL 60612, USA; deepedwa{at}uic.edu

Background/aims: Intraocular bone is seen in a wide spectrum of ocular disorders. The pathogenetic mechanisms of bone formation in the eye are unclear. Growth differentiation factor-5 (GDF-5), bone morphogenic protein-7 (BMP-7), and transforming growth factor beta-1 (TGF ß1) are multifunctional cytokines that have important roles in bone formation. Immunohistochemistry was used to localise GDF-5, BMP-7, and TGF ß1 in the human eye to determine their role in intraocular bone formation.

Methods: Paraffin embedded sections from human eyes included fetal eyes (n = 5), normal adult eyes (n = 4), eyes with osseous metaplasia (n = 8), and eyes with focal fibrous metaplasia of the retinal pigment epithelium (RPE) without osseous metaplasia (n = 2). Immunohistochemistry was performed using indirect immunofluorescence with antibodies to GDF-5, BMP-7, and TGF ß1. The staining intensity was evaluated semiquantitatively in the RPE, retina, ciliary epithelium, and cornea; and analysed statistically.

Results: When compared with normal adult eyes, which showed no RPE immunoreactivity, the RPE metaplasia surrounding areas of osseous metaplasia showed mild GDF-5 and moderate BMP-7 (p = 0.004) intracytoplasmic immunoreactivity. In contrast, trace GDF-5 and mild BMP-7 staining was seen in zones of RPE fibrous metaplasia in areas not associated with osseous metaplasia. Mild intracytoplasmic TGF ß1 expression was seen in the RPE metaplasia surrounding the bone when compared with adult eyes. Both fetal and adult eyes showed trace to mild GDF-5 and BMP-7 labelling of the non-pigmented ciliary epithelium which was increased in the eyes with osseous metaplasia. In eyes with osseous metaplasia, a significant decrease in GDF-5 and BMP-7 labelling was noted in fetal keratocytes (p = 0.0159 for both antibodies) when compared to adult eyes. Also, a significant decrease in BMP-7 labelling was seen in keratocytes in eyes with osseous metaplasia (p = 0.0162).

Conclusions: The increase in GDF-5, BMP-7, and TGF ß1 immunoreactivity in zones of RPE metaplasia in eyes with osseous metaplasia suggests that these proteins have an important role in intraocular ectopic bone formation.


Abbreviations: BMP-7, bone morphogenic protein-7; GDF-5, growth differentiation factor-5; RPE, retinal pigment epithelium; TGF ß1, transforming growth factor beta-1

Keywords: growth differentiation factor; bone morphogenic protein; transforming growth factor; osseous metaplasia; eye; cytokines




This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
T. W. Axelrad, B. Steen, D. W. Lowenberg, W. R. Creevy, and T. A. Einhorn
Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients
J Bone Joint Surg Br, December 1, 2008; 90-B(12): 1617 - 1622.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. J. Wordinger and A. F. Clark
Bone Morphogenetic Proteins and Their Receptors in the Eye
Experimental Biology and Medicine, September 1, 2007; 232(8): 979 - 992.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
L. Mecklenburg and U. Schraermeyer
An Overview on the Toxic Morphological Changes in the Retinal Pigment Epithelium after Systemic Compound Administration
Toxicol Pathol, February 1, 2007; 35(2): 252 - 267.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Sehgal, D. J. Andres, R. Adler, and T. L. Belecky-Adams
Bone morphogenetic protein 7 increases chick photoreceptor outer segment initiation.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3625 - 3634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.